Dr. Katharine Knobil
Board Member
Pliant Therapeutics, Inc. (PLRX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Katharine Knobil
Dr. Katharine Knobil is recorded as Board Member at Pliant Therapeutics, Inc. (PLRX). Pliant Therapeutics, Inc. reported in an 8-K filed September 16, 2022 that Dr. Katharine Knobil was appointed director, effective September 14, 2022.
“On September 14, 2022 (the “Effective Date”), the Board of Directors (the “Board”) of Pliant Therapeutics, Inc. (the “Company”) appointed, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, Dr. Katharine Knobil to fill a newly created Board seat in the class of directors whose term expires at the Company’s 2025 annual meeting of stockholders and to serve on the Research and Development Committee of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-09-14–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Pliant Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Bernard Coulie CEO, Board Member
- Keith Cummings CFO
- Minnie Kuo COO
- Mike Ouimette General Counsel
- Flavia Borellini, Ph.D. Board Member
- Gayle Crowell Board Member
- Robert Iannone, M.D., M.S.C.E. Board Member
- Steve Krognes Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.